Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06592183
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-23
Brief Title:
Speech Rehabilitation Based on Mobile Applications
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effect of Speech Rehabilitation Based on Mobile Application for People with Dysarthria After Stroke a Single-Center Investigator-Blinded Randomized Crossover Trial
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the efficacy of smartphone-based speech therapy administered at home compared with usual care Participants will be randomized into the treatment and waitlist control groups with an allocation ratio of 11
Detailed Description:
Despite the importance of dysarthria intervention in post-stroke rehabilitation further research in this area remains underexplored This study builds on previous research on the use of smartphone-based dysarthria interventions based on motor learning principles such as repetitive training and feedback and neuroplasticity through repetition motivation and reward The treatment duration of 1h 5 times a week for 4 weeks is consistent with previous behavioral interventions for post-stroke dysarthria This study aimed to determine whether the condition of patients with stroke can be improved through the use of smartphone-based interventions This is a single-center investigator-blinded randomized crossover effectiveness study In this study both the objective and subjective measurements will be performed three times at baseline post-phase 1 study week 4 and post-phase 2 study week 8 The study includes three intervention cycles and for each research cycle 12 subjects will be recruited to participate 6 per each group 3 cycles
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None